Background: Persons using daily subcutaneous injections to administer medicine perform them in different ways and thereby increase the risk of skin complications related to the injection. It is often part of nurses' role to administer medicine and educate the patient in injection technique. Course literature in nursing education, commercial patient education pamphlets, and instructional leaflets do not give consistent advice regarding subcutaneous injection technique.
INTRODUCTION

I
n Sweden, approximately 200,000 injections are administered subcutaneously every day (Apoteket 2001) . In Sweden, as in other countries, it is part of the nurse' s role to administer medication and teach patients how to inject correctly. Nurses, as well as patients, perform subcutaneous injections in different ways. This increases the risk of skin lesion and complications related to the injections. Epi-demiological studies have shown 30% prevalence of lipohypertrophy in insulin-treated patients (Becton Dickinson 2000) . It is therefore important that injection administration is based on scientific evidence of how best to perform this role. However, at present, it is difficult for nurses to incorporate best available evidence because literature used in nursing education, commercial patient information pamphlets, and instructional leaflets gives inconsistent advice regarding subcutaneous injection technique. These difficulties are not mitigated by compiled literature reviews, since the assessment process is not explicitly presented (e.g., Strauss et al. 1999) . Therefore, the aim of this study was to review, with a systematic approach, the scientific literature regarding the practical and technical performance of a subcutaneous injection. The specific question to be answered by the review was: How should a subcutaneous injection be administered to achieve the right dose in the right place with minimum complications?
METHOD
Using a traditional evidence-based practice approach, the following steps were taken: asking answerable questions, accessing best information, appraising information for validity and relevance, and applying information in patient care (Swedish Council on Technology Assessment in Health Care [SBU] 1993) . A subcutaneous injection includes several components. To identify these and to specify the search terms, Flemming' s work (Flemming 1998) was used as a guide. By defining the situation, intervention, counter intervention, and outcome of the intervention, three outcomes emerged: dose, location, and complication.
Inclusion criteria for studies to be examined were r published between the years 1966 and 2003 and written in English, German, Spanish, Swedish, or Danish; r the population investigated needed to be humanadults or children; r the equipment (i.e., syringes, needles, injection pens, etc.) used in the studies had to be in clinical use in Sweden from the 1980s and later; and r the intervention should be an injection into the subcutaneous fat layer, or the activities around it such as preparation of the dose, cleaning of the skin, etc.
Studies on intramuscular or intravenous injections were excluded. The preferred outcome was either right dose, right location, or report on any complications (see Table 1 ). To build a foundation for practice recommendations, the assumption was that included studies should have used descriptive or controlled methods.
The literature search was performed using the databases Medline and CINAHL. It was assumed that both these databases would include studies reporting on the administration of medication. The pedagogy-focused database ERIC was also searched, as teaching the patients the selfinjection technique is an important role of nurses. To identify other potential sources of evidence, written documen- (Strauss 1998 ) and in Barcelona in 2000 (Becton Dickinson 2000 for researchers with a special interest in injection technique was read, and some of the participants were contacted via e-mail for further information and documentation.
Literature Search
The literature search in Medline (via PubMed) was conducted in December 2003, using the MeSH (medical subject headings) terms: r "Injection, Subcutaneous" r "Needles" r "Insulin" r "Heparin Low-Molecular Weight" r "Nursing Evaluation Research" r "Lipodystrophy" r and the free text words "Injection Site" and "Subcuta-
The terms were used independently or in various combinations, using "AND." In the German search, the free text terms "Injektzion technik" AND "Diabetes" were used; in Spanish, the free text terms "Jeringa," "Inyeccion," "Diabetes Mellitus," "Enfermeria" were used. In the Danish search, the free text term used was "injektionsteknik," and the same term was used in the Swedish search.
The search in CINAHL was also conducted during December 2003, using subheadings:
r "Injection-Subcutaneous-Methods" r "Heparin-Administration-and-Dosage" r "Insulin-Administration-and-Dosage" r "Injections" r "Injection-Sites" r "Injection-Subcutaneous-Adverse-Effects" r "Syringes" r "Lipodystrophy"
The search in the database ERIC, using the search term Subcutaneous injection, did not identify any abstracts that could address the research question.
The references from previous literature reviews on this subject were manually searched Strauss et al. 1999) , and it was found that this search covered their included references.
A total of 102 abstracts were screened, using the inclusion criteria to select articles for further appraisal. From the 102 abstracts, 87 full-text articles were retrieved for closer screening; another 15 articles were received from European researchers. Criteria for this later screening included the following: whether the study had investigated right dose, right place, or complications; whether the injection studied had actually been subcutaneously placed and verified by CT scanning, ultrasound, or by lifting up a skin fold; and finally whether the problem studied was measurable with the method used. If there was no description of how the injection studied had been placed, and how this was controlled for in the study, the article was excluded. After excluding articles that did not meet this later criterion, 36 articles from Medline and CINAHL were included together with two from other researchers. Therefore, a total of 38 articles were critically appraised.
Assessment
The 38 full-text documents were assessed by two independent reviewers, using assessment sheets modified from available literature about critical appraisal (Greenhalgh 1997; Polit & Hungler 1999; Willman & Stoltz 2002) . The assessment sheet included data on the inclusion and exclusion criteria, the number of study subjects, what outcome was investigated, how this was measured, and whether the method chosen was appropriate. Data on the procedure for randomization, group comparability, blinding process, duration, and follow-up was also assessed, together with the statistical analysis. The reviewers met to compare and discuss their responses to the assessments. The quality for each article was graded on a three-point scale where one point refers to high scientific quality, three points refers to low scientific quality, and two points to moderate. This is the grading system used by the SBU for systematic reviews (SBU 1993 (SBU , 1997 (SBU , 2000 . The studies were divided into two groups: descriptive studies and controlled studies. No studies using a qualitative approach were identified.
The results of the assessment were integrated in evidence tables including the following information: name of the author, publishing year, country, method design, investigated population, intervention, outcome and quality level, a short summary of the author' s own result, the length of the needle used, and proven subcutaneous position.
FINDINGS
The 38 articles assessed for quality reported on many different aspects of the subcutaneous injections. In the quality assessment, 8 studies scored one point, 23 scored two points, and 7 scored three points. The eight one-point scoring studies are briefly presented below alongside the 23 two-point scoring studies in Tables 2, 3 , and 4. The studies are presented in three tables according to three different aspects of the research question: dose, location, or complications.
How to Achieve the Right Dose Bell et al. (1991) investigated, in a descriptive study of 90 patients and 28 health care professionals, the accuracy of dosage, using industrial pre-mixed insulin compared to self-mixed insulin. At low doses, both patients and professionals showed greater accuracy with achieving the right dose with pre-mixed insulin than with self-mixed insulin. Jehle et al. (1999) assessed whether Neutral Protamine Hagedorn (NPH) and insulin were accurately re-suspended by 109 patients measuring the content of their own vials and cartridges. Mixing of insulin by a mechanical device showed that at least 20 cycles of tipping the vial are necessary before complete re-suspension is achieved. Insulin content in patients' own cartridges or vials ranged from 5 to 214% of 100 IU/ml. The cartridge or vial was tipped and rolled more than 10 times by 9% of the patients. For all patients, there was a correlation between the absolute error of NPH insulin suspension and cycles of rolling and tipping the insulin (r = 0.23, p =< 0.05).
TABLE 3
How to achieve the right place et al. (1996) Existence of complications using 1-ml or 3-ml syringe How to Achieve the Right Place Birkebaek et al. (1998) in a descriptive study evaluated cutis/subcutis thickness on 47 children, at 11 measuring points at injection sites. Location of an air bolus injection with 8-mm and 12-mm needles was assessed by using ultrasound. The result showed that girls generally had more subcutaneous fat than boys and that compression of the skin reduced the distance from the surface to muscle fascia by 33%. The air bolus injection was inappropriately placed by 19% of the children using an 8-mm needle. Tubiana-Rufi et al. (1999) in a prospective crossover study of 50 children explored whether 8-mm needles could reduce the frequency of intra-muscular injections when compared with 12.7-mm needles. Using ultrasound, researchers assessed the localization of the needle tip on injection of insulin. The result showed that 88% of the children had < 12.7 mm and 40% had < 8-mm subcutaneous fat at the injection sites.
At the time of the study, the needles most commonly used were 8 mm or 12.7 mm in length. Of the 50 injections performed with a 12.7-mm needle in a two-finger-pinch lifted skin fold, 86% were placed in the muscle instead of the fat layer. With an 8-mm needle, 38% of the 50 injections were placed in the muscle instead of the subcutaneous fat layer. McGowan and Wood (1990) in an experimental study compared the relationship between four different injection techniques and bruising after an injection with heparin. The injections were given to 96 patients, using a 16-mm needle. There was no statistical difference between the four injection techniques used and the existence of bruises. Ross and Soltes (1995) in a quasi-experimental study compared whether ice applied on the skin pre-and post-injection with heparin on 70 healthy volunteers had any impact on the existence of, and size of, haematoma. The result of 141 injections with a 16-mm needle in a lifted skin fold showed no significant difference in the incidence or size of hematoma. Hadley et al. (1996) assessed incidence and size of haematoma after heparin injection with a 1-ml syringe and a 3-ml syringe in a lifted skin fold in 29 patients (n = 58 injections). The incidence of bruising did not differ significantly between 1-ml and 3-ml syringes, but the use of a 3-ml syringe resulted in significantly smaller bruises. Le Floch et al. (1998) conducted a prospective study with 120 patients. A nurse injected insulin with the patient' s own insulin pen and an 8-mm or a 12.7-mm needle. A cytopathological examination was performed on the material obtained from the needles and found in the cartridge after the injection. Air bubbles were found in 45% of the cartridges. Biologic material was found in 30% of the needles and in 58% of the cartridges, and in 25% of both needle and cartridge.
How to Achieve Minimum Complications
These 38 studies included here do investigate different aspects of the subcutaneous injection technique, but they differ in study design, subjects included, and outcomes measured. Therefore, it is difficult to formulate clear recommendations. From the literature reviewed here, there is no evidence to support general recommendations for the technical performance of the subcutaneous injection. Conclusions might be made from the findings-that the size of the injection needle should be adjusted to the amount of subcutaneous fat a person has. In practice, this amount can sometimes be difficult to estimate. Complications in connection with heparin injection seem to depend more on heparin itself rather than the injection technique used. The research evidence also seems to point toward individualizing care. However, to achieve this, the practitioner needs an explicit practice foundation so that she/he knows how individual changes should and can be made.
DISCUSSION
The result of this literature review reveals that there is little research evidence to support the formulation of recommendations regarding the performance of subcutaneous injection.
The fact that studies have been performed on many different aspects of subcutaneous injection reveals that this is an important clinical area for nurses and others. The most relevant approach to measuring effectiveness is a wellconducted randomized clinical trial. This design is difficult to perform on injection technique, since many of its components cannot (like choice of injection site), or should not (like dose accuracy), be blinded. To provide information regarding anatomical facts, such as fat depth, descriptive studies are relevant and indeed were included in this literature review. Case studies are informative regarding complications but are not a sufficient foundation for general conclusions and were therefore excluded. In the abstracts from Medline and CINAHL, several articles included 1-to 10-step instructions about how to perform an injection. These abstracts were excluded, since there is no convincing evidence that a certain technique is better than another just because it has been practiced for a long time. However, the frequent occurrence of step-by-step instructions reveals the need for further research, to build up a scientific foundation for such instructions.
Ideally after the search for studies has begun, the inclusion and exclusion criteria used should not be modified (SBU 1993) . However, with regards to this particular review, it was soon revealed that many studies before 1980 were performed with injection tools no longer in use in Sweden. Therefore, studies published before 1980 were excluded from the result except for one that had studied skin bacteria, as alcohol swab is still in use (Koivisto & Felig 1978) .
The use of MeSH terms in Medline became cumbersome. The initial search turned out to include clinical trials regarding any medication intended for injection, giving a lot of pharmacological information but no information about which injection technique had been used. This is a weakness in the reporting of a new drug, as there is no information about whether the correct dose is given in the intended tissue. The abstracts from the chosen subheadings in CINAHL were surprisingly often medically oriented, referring to medical effects or side effects of different drugs, with little or no information on the injection technique or other nursing aspects.
Of the published studies, only a small number were performed on persons suffering from diabetes mellitus type 2, in spite of the fact that these patients constitute the largest group receiving subcutaneous injections in Sweden and many other countries. Many of the excluded studies regarding absorption of drugs could not be included, as the authors did not explain how the injection had been performed and whether the injection had reached the intended fat tissue or not. Several studies on heparin injection had more than one dependent variable, which makes it hard to draw any conclusions. Previous literature reviews included studies covered by this search, but the authors did not explain how the selection of included articles had been carried out.
Implications for research and practice r Habits and practices of people who inject medication subcutaneously need to be described further, including the existence of injection-related complications. r Factors that influence patients' actual injection technique compared to nurses' recommendations need to be investigated. r Differences in the rate of injection complications in people receiving injections from nurses/health care staff compared with people taking the injections themselves need to be explored. r More studies should target diabetes type 2 patients, obese people, and elderly people, as these are the largest groups receiving insulin (and low-weightheparin) injections. r Methods for estimation of subcutaneous fat tissue need to be evaluated to facilitate the choice of correct injection equipment and needle length. r Studies on people with different skin colour could facilitate the development of methods to identify skin complications.
r Studies need to be done on the leakage of drugs at the injection site and the eventual clinical importance of drug leakage. r Injections sites should have a sufficient amount of fat. r Children and lean adults need short needles to avoid intra-muscular injection. r Patients need instruction and follow-up when beginning self-injection therapy. r Injection sites should be systematically inspected and routinely documented.
